Oxurion NV Stock Price Today | EBR OXUR Live Ticker - Investing.com
www.investing.com › thrombogenics
View today's Oxurion NV stock price and latest OXUR news and analysis. Create real-time notifications to follow any changes in the live stock price.
Beoordeling
· Review door Stockopedia
Discover all the factors affecting Oxurion NV's share price. OXUR is currently rated as a Sucker Stock | Stockopedia.
Complete Oxurion N.V. stock information by Barron's. View real-time OXUR stock price and news, along with industry-best analysis ... OXUR. 0.00. 0.00%. Apr 12 ...
Beoordeling
· Review door Simply Wall St
Research Oxurion's (ENXTBR:OXUR) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more.
Shares Out. 5,753.95 MM. Earnings Date. EPS (TTM). Dividend Yield. Ex-Dividend Date.
Beoordeling
· Review door Stockopedia
Review the latest Balance Sheet Statement for Oxurion NV (EBR:OXUR) - including Assets, Liabilities, and Equity figures.
Although the technical rating is bad, OXUR does present a nice setup opportunity. Prices have been consolidating lately and the volatility has been reduced.
View today's Oxurion NV stock price and latest OXUR news and analysis. Create real-time notifications to follow any changes in the live stock price.
Oxurion NV, a biopharmaceutical company, develops and commercializes medicines for the treatment of eye diseases in Belgium and internationally.
10 mei 2023 · The average one-year price target for ThromboGenics (EBR:OXUR) has been revised to 0.94 / share. This is an decrease of 26.40% from the ...